Colon Signet Ring Cell Adenocarcinoma — Trials

Colon Signet Ring Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01802320	Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery	completed	Phase 2	18	National Cancer Institute (NCI)NIH	1	Sep 20, 2019	clinicaltrials
NCT01198535	Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer	terminated	Phase 1	60	National Cancer Institute (NCI)NIH	1	May 18, 2015	clinicaltrials